Header Logo

Connection

ARGUN AKCAKANAT to Mitogen-Activated Protein Kinase Kinases

Back to Details
This is a "connection" page, showing publications ARGUN AKCAKANAT has written about Mitogen-Activated Protein Kinase Kinases.
ARGUN AKCAKANAT
Connection Strength
0.069
Mitogen-Activated Protein Kinase Kinases
  1. Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations. Sci Rep. 2022 01 24; 12(1):1248.
    View in: PubMed
    Score: 0.042
  2. Epithelial to mesenchymal transition is associated with rapamycin resistance. Oncotarget. 2015 Aug 14; 6(23):19500-13.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.